Skip to main content

Table 3 Comparison of psychoactive drugs use and other treatments in Sub-threshold Depression (HRDS > 10 without criteria for lifetime Depressive Episode) = SD; subjects with Depressive Episode point prevalence = DE and in the overall sample without Depression (SD or DE) = ND

From: Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder

  2. SD 3. DE 1. ND Overall Sample Χ2 2DF P
Total 137 (4.0) 55 (1.6) 3206 (94.3) 3398   
°First line Antidepressants 20 (14.6) 17 (30.9) 69 (2.1) 106 (3.1) 210.2 0.0001
§Second line Antidepressants 7 (5.1) 14 (25.4) 32 (1.0) 53 (1.6) 14.7 0.0001
*Benzodiazepines 40 (29.1) 14 (25.4) 188 (5.8) 242 (7.1) 147.9 0.0001
°°Homeopathics 4 (2.9) 0 21 (0.6) 25 (0.7) 8.1 0.018
**Psychotherapies 13 (9.5) 8 (17.8) 50 (1.5) 71 (2.1) 95.3 0.0001
  1. °Homogeneity by cells: 1vs2, χ2 = 74.1, 1DF P < 0.0001; 1vs3, χ2 = 205.7, 1DF P < 0.0001; 2vs3 χ2 = 9.8, 1DF 0.002; §Homogeneity by cells: 1vs2, χ2 = 12.5, 1DF P < 0.0001; 1vs3, χ2 = 76.3, 1DF P < 0.0001; 2vs3, χ2 = 14.6, P < 0.0001; 2vs3 χ2 = 5.6, 1DF P = 0.018; * Homogeneity by cells: 1vs2, χ2 = 109.4, 1DF P < 0.0001; 1vs3, χ2 = 44.5, 1DF P < 0.0001; 2vs3 χ2 = 0.1, 1DF NS; °° Homogeneity by cells: 1vs2, χ2 = 4.6, 1DF P < 0.031; 1vs3, χ2 = 0.1, 1DF NS; 2vs3 χ2 = 0.3, 1DF NS; ** Homogeneity by cells: 1vs2, χ2 = 40.4, 1DF P < 0.0001; 1vs3, χ2 = 45.0, 1DF P < 0.0001; 2vs3 χ2 = 0.5, 1DF NS